论文部分内容阅读
目的:评价呋塞米雾化吸入治疗支气管哮喘患者对肺功能改善的临床疗效。方法:选取2013年7月—2015年9月间收治的支气管哮喘患者90例,将其分为对照组和观察组(每组45例);两组患者均给予支气管哮喘常规治疗,观察组患者在此基础上给予呋塞米注射液超声雾化吸入治疗,对照组患者给予硫酸庆大霉素注射液和注射用糜蛋白酶雾化吸入治疗,治疗过程中给予患者适当的护理干预,比较两组患者治疗后的总有效率,以及治疗前后肺功能各指标值。结果:观察组患者治疗后的总有效率为91.11%明显高于对照组为73.33%(P<0.05);治疗前两组患者的最大呼气流量(Peak Expiratory Flow,简称PEF)和第1秒用力呼气容积(Forced Expiratory Volume in One Second,简称FEV1)值之间经比较其差异无统计学意义(P>0.05),治疗后观察组患者的PEF、FEV1值明显高于对照组(P<0.05)。结论:呋塞米雾化吸入治疗支气管哮喘患者,其改善肺功能的疗效优于硫酸庆大霉素注射液和糜蛋白酶雾化吸入的疗效。
OBJECTIVE: To evaluate the clinical efficacy of furosemide inhalation in the treatment of patients with bronchial asthma to improve pulmonary function. Methods: Ninety patients with bronchial asthma were selected from July 2013 to September 2015, which were divided into control group and observation group (45 cases in each group). Both groups were given conventional bronchial asthma treatment. Patients in observation group On the basis of furosemide injection given ultrasonic atomization inhalation therapy, patients in the control group were given gentamicin sulfate injection and injection of chymotrypsin inhalation therapy, patients given appropriate nursing intervention during treatment, the two groups were compared The total effective rate of patients after treatment, as well as before and after treatment of lung function index values. Results: The total effective rate in observation group was 91.11%, which was significantly higher than that in control group (73.33%, P <0.05). The peak expiratory flow (PEF) Forced Expiratory Volume in One Second (FEV1 for short) was no significant difference between the two groups (P> 0.05). After treatment, the PEF and FEV1 values in the observation group were significantly higher than those in the control group (P < 0.05). Conclusion: The efficacy of inhalation of furosemide in patients with bronchial asthma is better than that of injection of gentamicin sulfate and chymotrypsin in inhalation.